Verano Holdings (VRNO) EBIT Growth (1y) (2022 - 2026)

Verano Holdings (VRNO) EBIT Growth (1y) (2022 - 2026) Analysis & Trends

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) EBIT Growth (1y) (Qtr)
1 Teva Pharmaceutical Industries 39.72 Bn 35.98 Bn 1.97 Bn 25.63%
2 Zoetis 34.61 Bn 32.67 Bn 1.62 Bn -1.30%
3 United Therapeutics 24.07 Bn 21.91 Bn 648.10 Mn -14.89%
4 Aurora Cannabis 16.98 Bn 16.91 Bn 33.43 Mn -46.83%
5 Neurocrine Biosciences 16.64 Bn 15.32 Bn 800.70 Mn 719.49%
6 Elanco Animal Health 12.19 Bn 11.76 Bn 785.00 Mn 23.29%
7 Alkermes 7.37 Bn 6.86 Bn -116.06 Mn -450.06%
8 Hims & Hers Health 6.62 Bn 5.87 Bn 396.79 Mn -235.28%
9 Lantheus Holdings 6.47 Bn 5.97 Bn 230.92 Mn -20.32%
10 Verano Holdings - - 98.98 Mn -12.68%

Historic Data

Download Data
DateValue
Mar 31, 2026 -12.68%
Dec 31, 2025 48.14%
Sep 30, 2025 -44.68%
Jun 30, 2025 -3.87%
Mar 31, 2025 -33.83%
Dec 31, 2024 -1,441.77%
Sep 30, 2024 -58.37%
Jun 30, 2024 -10.40%
Mar 31, 2024 -32.89%
Dec 31, 2023 90.48%
Sep 30, 2023 8.67%
Jun 30, 2023 1,427.66%
Mar 31, 2023 1,962.39%
Dec 31, 2022 -803.29%
Sep 30, 2022 61.10%
Jun 30, 2022 -1,350.63%